協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2015/02/18 | 1,392 | 1,398 | 1,376 | 1,388 | +4 | +0.3% | 1,301,000 |
| 2015/02/17 | 1,387 | 1,392 | 1,380 | 1,384 | -16 | -1.1% | 937,000 |
| 2015/02/16 | 1,406 | 1,412 | 1,386 | 1,400 | -6 | -0.4% | 858,000 |
| 2015/02/13 | 1,417 | 1,423 | 1,396 | 1,406 | -12 | -0.8% | 1,969,000 |
| 2015/02/12 | 1,380 | 1,424 | 1,375 | 1,418 | +63 | +4.6% | 2,092,000 |
| 2015/02/10 | 1,362 | 1,377 | 1,341 | 1,355 | -19 | -1.4% | 1,460,000 |
| 2015/02/09 | 1,372 | 1,380 | 1,364 | 1,374 | +10 | +0.7% | 942,000 |
| 2015/02/06 | 1,350 | 1,368 | 1,339 | 1,364 | +24 | +1.8% | 1,082,000 |
| 2015/02/05 | 1,350 | 1,356 | 1,331 | 1,340 | -8 | -0.6% | 1,525,000 |
| 2015/02/04 | 1,360 | 1,363 | 1,338 | 1,348 | -6 | -0.4% | 2,389,000 |
| 2015/02/03 | 1,368 | 1,374 | 1,346 | 1,354 | +2 | +0.1% | 2,136,000 |
| 2015/02/02 | 1,341 | 1,372 | 1,340 | 1,352 | +4 | +0.3% | 1,851,000 |
| 2015/01/30 | 1,346 | 1,360 | 1,332 | 1,348 | +12 | +0.9% | 2,114,000 |
| 2015/01/29 | 1,325 | 1,347 | 1,315 | 1,336 | -7 | -0.5% | 1,527,000 |
| 2015/01/28 | 1,305 | 1,353 | 1,301 | 1,343 | +36 | +2.8% | 2,566,000 |
| 2015/01/27 | 1,269 | 1,307 | 1,264 | 1,307 | +85 | +7% | 3,039,000 |
| 2015/01/26 | 1,207 | 1,224 | 1,204 | 1,222 | +11 | +0.9% | 1,381,000 |
| 2015/01/23 | 1,220 | 1,220 | 1,202 | 1,211 | +1 | +0.1% | 1,671,000 |
| 2015/01/22 | 1,200 | 1,211 | 1,193 | 1,210 | +11 | +0.9% | 1,731,000 |
| 2015/01/21 | 1,186 | 1,200 | 1,181 | 1,199 | -1 | -0.1% | 1,698,000 |
| 2015/01/20 | 1,171 | 1,201 | 1,169 | 1,200 | +29 | +2.5% | 1,561,000 |
| 2015/01/19 | 1,148 | 1,172 | 1,146 | 1,171 | +42 | +3.7% | 1,620,000 |
| 2015/01/16 | 1,129 | 1,135 | 1,110 | 1,129 | -26 | -2.3% | 1,866,000 |
| 2015/01/15 | 1,119 | 1,158 | 1,119 | 1,155 | +41 | +3.7% | 1,827,000 |
| 2015/01/14 | 1,131 | 1,141 | 1,111 | 1,114 | -41 | -3.5% | 1,719,000 |
| 2015/01/13 | 1,133 | 1,155 | 1,131 | 1,155 | +16 | +1.4% | 1,437,000 |
| 2015/01/09 | 1,150 | 1,151 | 1,129 | 1,139 | +1 | +0.1% | 1,766,000 |
| 2015/01/08 | 1,109 | 1,144 | 1,109 | 1,138 | +39 | +3.5% | 1,455,000 |
| 2015/01/07 | 1,096 | 1,109 | 1,094 | 1,099 | -2 | -0.2% | 1,003,000 |
| 2015/01/06 | 1,120 | 1,124 | 1,101 | 1,101 | -32 | -2.8% | 1,693,000 |
| 2015/01/05 | 1,125 | 1,141 | 1,118 | 1,133 | -3 | -0.3% | 1,199,000 |
| 2014/12/30 | 1,146 | 1,149 | 1,135 | 1,136 | -11 | -1% | 958,000 |
| 2014/12/29 | 1,157 | 1,162 | 1,135 | 1,147 | -3 | -0.3% | 1,031,000 |
| 2014/12/26 | 1,161 | 1,162 | 1,150 | 1,150 | -13 | -1.1% | 784,000 |
| 2014/12/25 | 1,167 | 1,167 | 1,156 | 1,163 | +5 | +0.4% | 1,025,000 |
| 2014/12/24 | 1,167 | 1,168 | 1,152 | 1,158 | +2 | +0.2% | 1,272,000 |
| 2014/12/22 | 1,160 | 1,160 | 1,151 | 1,156 | +11 | +1% | 876,000 |
| 2014/12/19 | 1,173 | 1,175 | 1,140 | 1,145 | -23 | -2% | 2,567,000 |
| 2014/12/18 | 1,164 | 1,173 | 1,158 | 1,168 | +25 | +2.2% | 1,557,000 |
| 2014/12/17 | 1,142 | 1,153 | 1,140 | 1,143 | ±0 | ±0% | 1,490,000 |
| 2014/12/16 | 1,150 | 1,159 | 1,139 | 1,143 | -7 | -0.6% | 1,971,000 |
| 2014/12/15 | 1,173 | 1,175 | 1,147 | 1,150 | -25 | -2.1% | 1,857,000 |
| 2014/12/12 | 1,175 | 1,184 | 1,156 | 1,175 | -37 | -3.1% | 5,664,000 |
| 2014/12/11 | 1,237 | 1,244 | 1,210 | 1,212 | -34 | -2.7% | 2,060,000 |
| 2014/12/10 | 1,264 | 1,272 | 1,243 | 1,246 | -43 | -3.3% | 1,216,000 |
| 2014/12/09 | 1,273 | 1,291 | 1,268 | 1,289 | +4 | +0.3% | 607,000 |
| 2014/12/08 | 1,298 | 1,304 | 1,280 | 1,285 | -11 | -0.8% | 1,066,000 |
| 2014/12/05 | 1,297 | 1,299 | 1,287 | 1,296 | -9 | -0.7% | 797,000 |
| 2014/12/04 | 1,306 | 1,308 | 1,300 | 1,305 | +14 | +1.1% | 592,000 |
| 2014/12/03 | 1,298 | 1,304 | 1,287 | 1,291 | -7 | -0.5% | 952,000 |
2501～
2550
件表示中 / 3698件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 217,400円 | -3.5% | -11.3% | 2.76% | 19.97倍 | 1.34倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 135,300円 | +0.9% | +380.2% | 5.76% | 18.63倍 | 1.60倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 220,700円 | +20.9% | +10.6% | 2.99% | 10.43倍 | 1.38倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 388,100円 | +1.7% | -2.9% | 4.12% | 25.46倍 | 1.34倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 150,100円 | +0.6% | +43.3% | 5.33% | 10.52倍 | 0.90倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
